Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-28 4:05 pm Purchase |
2023-02-23 | 13G | Enliven Therapeutics, Inc. ELVN |
Commodore Capital LP | 1,448,640 3.500% |
1,448,640 (New Position) |
Filing History |
| 2023-02-21 4:05 pm Purchase |
2023-02-15 | 13G | IMARA Inc. IMRA |
Commodore Capital LP | 710,189 10.800% |
86,490 (+13.87%) |
Filing History |
| 2023-02-16 4:05 pm Purchase |
2023-02-06 | 13G | Vera Therapeutics, Inc. VERA |
Commodore Capital LP | 2,342,857 5.600% |
2,342,857 (New Position) |
Filing History |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | IMARA Inc. IMRA |
Commodore Capital LP | 623,699 9.500% |
249,221 (+66.55%) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Commodore Capital LP | 129,041 1.700% |
-138,363 (-51.74%) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Commodore Capital LP | 0 0.000% |
-348,530 (Position Closed) |
Filing History |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Commodore Capital LP | 2,020,166 5.000% |
2,020,166 (New Position) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | BELLUS Health Inc. BLU |
Commodore Capital LP | 5,303,557 4.200% |
-153,553 (-2.81%) |
Filing History |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
Commodore Capital LP | 5,738,500 6.800% |
318,604 (+5.88%) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Immunic, Inc. IMUX |
Commodore Capital LP | 2,873,563 6.300% |
-893,013 (-23.71%) |
Filing History |
| 2023-02-14 4:05 pm Purchase |
2022-12-31 | 13G | Celcuity Inc. CELC |
Commodore Capital LP | 2,257,412 9.900% |
1,336,948 (+145.25%) |
Filing History |
| 2023-02-14 4:05 pm Purchase |
2022-12-31 | 13G | Merus N.V. MRUS |
Commodore Capital LP | 2,732,567 5.900% |
490,343 (+21.87%) |
Filing History |
| 2023-02-14 4:05 pm Purchase |
2022-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Commodore Capital LP | 4,926,000 7.000% |
2,644,685 (+115.93%) |
Filing History |
| 2023-01-13 4:05 pm Purchase |
2023-01-03 | 13G | Cabaletta Bio, Inc. CABA |
Commodore Capital LP | 1,458,367 5.000% |
1,458,367 (New Position) |
Filing History |
| 2022-11-16 4:10 pm Sale |
2022-11-14 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Commodore Capital LP | 0 0.000% |
-3,711,286 (Position Closed) |
Filing History |
| 2022-10-24 4:31 pm Purchase |
2022-10-13 | 13G | IMARA Inc. IMRA |
Commodore Capital LP | 374,478 5.700% |
374,478 (New Position) |
Filing History |
| 2022-10-21 5:15 pm Purchase |
2022-10-12 | 13G | Immunic, Inc. IMUX |
Commodore Capital LP | 3,766,576 9.300% |
3,766,576 (New Position) |
Filing History |
| 2022-05-19 4:30 pm Purchase |
2022-05-09 | 13G | Viridian Therapeutics, Inc. VRDN |
Commodore Capital LP | 1,371,339 5.000% |
1,371,339 (New Position) |
Filing History |
| 2022-05-16 4:30 pm Purchase |
2022-05-06 | 13G | Merus N.V. MRUS |
Commodore Capital LP | 2,242,224 5.100% |
2,242,224 (New Position) |
Filing History |
| 2022-05-09 4:30 pm Purchase |
2022-04-27 | 13G | Karyopharm Therapeutics Inc. KPTI |
Commodore Capital LP | 267,403 5.100% |
267,403 (New Position) |
Filing History |